NevadaAB25983rd Regular Session (2025)HouseWALLET

AN ACT relating to health care; prohibiting certain actions related to pricing and reimbursement for certain drugs; creating a cause of action for violating such prohibitions; and providing other matters properly relating thereto.

Sponsored By: Venicia Considine (Democratic)

Vetoed

BDR 40-165

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

3 provisions identified: 3 benefits, 0 costs, 0 mixed.

Price caps for Nevada drug purchasers

Beginning January 1, 2026, Nevada drug purchasers cannot pay above the federal maximum fair price for covered drugs. The same ceiling limits reimbursement requests for drugs delivered, dispensed, or administered in Nevada. These limits apply only during each drug’s federal price applicability period and exclude pharmacy dispensing fees. Federal employee health coverage providers, ERISA health coverage providers, and Taft-Hartley trusts are exempt unless they choose to participate. They must notify the Director in writing by January 1 of each participating year. Contracts entered before January 1, 2026, remain exempt, but renewals and extensions are covered. The state can adopt rules to carry out the cap, with preparation authorized upon passage and approval. The cap may lower purchasing costs, but it does not guarantee lower patient bills.

People harmed by drug violations can sue

Beginning January 1, 2026, people harmed by violations of the drug price or reimbursement limits can bring consumer-fraud lawsuits. Those who win may recover proven damages, court-ordered relief, court costs, and reasonable lawyer fees. These lawsuits are not treated as contract claims, and recovery is not guaranteed. Each payment or reimbursement request above the limit counts as a separate deceptive trade practice. State officials can also seek to suspend a violator’s right to do business in Nevada or dissolve a company. Violating related court orders can bring civil penalties up to $10,000 per violation. A court finding of willful deception can bring penalties up to $15,000 per violation.

Drug price violators avoid specified criminal penalties

Beginning January 1, 2026, drug price or reimbursement violations are exempt from the specified criminal penalties for deceptive trade practices. This exemption protects violators from those criminal penalties, not from all legal consequences. The price limits, consumer-fraud lawsuits, and civil enforcement still apply.

Sponsors & Cosponsors

Sponsor

  • Venicia Considine

    Democratic • House

Cosponsors

  • Natha C. Anderson

    Democratic • House

Roll Call Votes

All Roll Calls

Yes: 40 • No: 23

Senate vote • 6/2/2025

Final Passage - Senate (1st Reprint)

Yes: 13 • No: 8

House vote • 5/27/2025

Final Passage - Assembly (2nd Reprint)

Yes: 27 • No: 15

Actions Timeline

  1. Vetoed by the Governor.

    6/12/2025legislature
  2. Enrolled and delivered to Governor.

    6/6/2025legislature
  3. In Assembly. To enrollment.

    6/4/2025House
  4. To Assembly.

    6/2/2025Senate
  5. Read third time. Passed. Title approved. Preamble adopted. (Yeas: 13, Nays: 8.)

    6/2/2025Senate
  6. Taken from General File. Placed on General File for next legislative day.

    6/1/2025Senate
  7. Taken from General File. Placed on General File for next legislative day.

    5/31/2025Senate
  8. Read second time.

    5/30/2025Senate
  9. Placed on Second Reading File.

    5/30/2025Senate
  10. From committee: Do pass.

    5/30/2025Senate
  11. Read first time. Referred to Committee on Finance. To committee.

    5/28/2025Senate
  12. In Senate.

    5/28/2025Senate
  13. Read third time. Passed, as amended. Title approved. Preamble adopted. (Yeas: 27, Nays: 15.) To Senate.

    5/27/2025House
  14. Placed on General File.

    5/27/2025House
  15. From committee: Do pass, as amended.

    5/27/2025House
  16. From printer. To engrossment. Engrossed. First reprint. To committee.

    4/22/2025House
  17. To printer.

    4/17/2025House
  18. Rereferred to Committee on Ways and Means. Exemption effective.

    4/17/2025House
  19. Taken from General File.

    4/17/2025House
  20. Read second time. Amended. (Amend. No. 156.)

    4/17/2025House
  21. From committee: Amend, and do pass as amended.

    4/16/2025House
  22. Notice of eligibility for exemption.

    3/10/2025House
  23. From printer. To committee.

    2/20/2025House
  24. Read first time. Referred to Committee on Commerce and Labor. To printer.

    2/19/2025House

Bill Text

Related Bills

Back to State Legislation